NCT04452357View on ClinicalTrials.gov

Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Pancreatic Cancer
Interventions
RADIATION

PLDR

"PLDR radiation will be delivered as 10 fractions of 20 cGy, initiated once every 3 minutes. Dose levels will be selected as follows:~Dose level 1: 56 Gy; Dose level 2: 66 Gy Drug: Gemcitabine"

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
lead

Fox Chase Cancer Center

OTHER